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Abstract
The current radiosensitive studies are described with linear-quadratic (LQ) cell
survival (S) model for one fraction with a dose d. As result of assuming all suble-
thally damaged cells (SLDCs) are completely repaired during the interfractions,
that is, no presence of SLDCs, the survived cells are calculated for a n-fractionated
regimen with the LQ S(n,D) model. A mathematically processed subpart of
LQS(n,D) is the biologically effective dose (BED) that is used for evaluating a
so-called “biological dose.” The interactions of ionizing radiation with a living tissue
can produce partial death or sublethal damage from healthy or sublethally damaged
cells. The proportions of the killed and sub-lethally damaged cells define the radia-
tion biological effects (RBEfs). Computational simulations using RBEFs for frac-
tionated regimens let calculating tumor control probability. While the derivation of
the LQ S(n,D) considers a 100% cell repair, that is, 0% of sublethally damaged cells
(SLDCs), the radiobiological simulators take into account the presence of SLDCs, as
well as a cell repair <100% during the interfractions and interruption. Given “bio-
logical dose” does not exist, but RBEf, there was need for creating the BED. It is
shown how some uses of BED, like the derivation of EQ2D expression, can be done
directly with the LQ S(n,D).
Keywords: BED, simulation, radiotherapy, brachytherapy, fractionation,
linear-quadratic model, mathematical models, radiobiology
1. Introduction
In 1989, an article published in [1] introduced the term BED, biologically effec-
tive dose, as a linear-quadratic (LQ)-based formula. After 21 years, a new article
was published in [2] for showing the wide use of BED in the radiation therapies. In
this work, the BED was defined (of a given schedule) as: “the total dose required to
give the same log cell kill as the schedule being studied, at an infinitely low dose-
rate or with infinitely small fractions well-spaced out; now with an overall time
factor for repopulation during continued irradiation.”
When ionizing radiation interacts with a determined volume of living tissue, this
can or cannot interact with all cells, can or cannot produce effects as result of their
interactions; and the first fraction of a fractionated treatment produces a partial
number of killed and sublethally damaged cells (SLDCs) from the total initially
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undamaged ones. During the second and successive fractions, the radiation can
interact with these three kinds of cells, where the interactions can produce the same
effects of the first fraction from the undamaged cells and SLDCs.
BED has direct relationship with the radiation biological effects (RBEfs), in
particular the cell survival (S) in radiation treatments with n fractions, d dose per
fractions delivered in tissues characterized with LQ parameters α and α/β. The BED
expression was a result of a mathematical derivation of the exponential part of the
LQ S model for treatments with n fractions and dose per fraction d, the LQ S(n,D)
where D = nd; and this model was obtained assuming that all sublethally damaged
cells are wholly repaired during the interfraction period.
“BED is a measure of the true biological dose delivered by a particular combina-
tion of dose per fraction and total dose to a particular tissue characterized by a
specific α/β ratio” [3]. This expression is incoherent because only the physical dose
is delivered, and produces biological effects. There is no “biological dose.”
The mathematical formulas have traditionally been used for calculating physical
quantifications of deterministic and stochastic processes/effects (SP/Es). At this
time there is high development in the computer science, where the computational
simulators allow us determining probabilistic metrics some SP/Es, such as their
means and probabilities, based on simulations of many possible cases.
The RBEfs should be estimated with computational radiobiological simulators or
with the current LQ S(n,D) model.
2. The biologically effective dose (BED)
Nowadays, the radiosensitivity studies function of the absorbed dose (d) are
described with the cell survival (S), which is complement of cell kill (K), and
probabilistically S = 1-K. These studies are widely modeled with the LQ S(d) for one
fraction as
LQS dð Þ ¼ exp αd βd2
 
(1)
where α and β are the LQ parameters.
d: dose of one fraction.
As result of assuming all sublethally damaged cells (SLDCs) are completely
repaired during the interfractions, that is, no presence of SLDCs, the survived cells
are calculated for a n-fractionated regimen as
LQS n,Dð Þ ¼ LQ S dð Þ½ n ¼ exp αD βD2=n
 
(2)
where D = n*d.
A mathematically processed subpart of LQ S(n,D) is the BED that is used for
evaluating a called “biological dose,” and is written as
BED ¼ D 1þ
d
∝=β
 
(3)
As an inherent part of the LQ S(n,D) model, the origin of BED is explained in [4]
the following way.
1.The radiation cell kill (or effect, E) can be expressed as
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Cell kill ¼ E ¼ n αdþ βd2
 
(4)
2.Consider a progressive reduction in d such that it approaches a value of zero.
Although the number of fractions n will then need to be increased to maintain
the same effect, βd
2
will be very small in comparison with ad (since d will
greatly exceed d
2
for very small values and α always exceeds β). Therefore,
when d is very small, Eq. (4) is approximated as
E ¼ nαd ¼ αD (5)
3.This demonstrates that the total dose (D) of radiotherapy given at a very low
dose per fraction represents the highest total dose required to obtain a specific
effect. The total dose required in these conditions constitutes the definition of
BED in situations where cellular repopulation can be ignored, that is, in this
limiting case:
BED ¼ D ¼ E=α (6)
The authors of [4] considered that: “BED represents the physical dose required
for a given effect if the dose were to be delivered by infinitely small doses per
fraction or, in the case of continuous radiation rates, at a very low dose rate.”
The procedure used in [4] is purely mathematical, since the cell kill (K) and its
complement, the cell survival (S), are stochastic effects with a deterministic region
for low values of d, where D does not produce any effect, that is, there will be 100%
of S; i.e. 0% of K.
To date, except the probabilistic treatments of the tumor control/normal tissue
complication probability (TCP/NTCP), many stochastic processes/effects in areas
of the ionizing radiations interacting with living tissues have not been probabilisti-
cally treated nor modeled, which has led deficiencies, like replacement in the
evaluations of cell survival (S)—a probabilistic metric—by BED, a non-probabilistic,
a mathematical derivation from the LQ S(n,D) formalism.
2.1 The BED in radiotherapy
In [4], the authors have shown the use of BED in practical situations for normal
tissues. For example, if a dose of 60 Gy in 30 fractions is received by a critical
normal tissue, the associated BED may (for example) be expressed in terms of
Gy1.5, Gy2, and Gy3 (for α/β ratios of 1.5, 2, and 3 Gy). The initial BED value for a
fractionation schedule of 60 Gy in 30 fractions (BED = 140Gy1.5) is used to calculate
the total dose and dose per fraction for the alternative schedule of 20 fractions. The
result for alternative fractionation schedule is obtained from the solution of d in a
rearrangement of following equation
20d 1þ
d
1:5
 
¼ 140Gy1:5 (7)
Really, we can use the Eq. (2) for determining the previous alternative fraction-
ation schedule (n2 fractions and d2 dose per fractions) without need of creating the
BED, based on the following procedure
LQS n1,D1ð Þ ¼ LQS n2,D2ð Þ (8)
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where D1 = n1d1 and D2 = n2d2
exp αD1  βD1
2=n1
 
¼ exp αD2  βD2
2=n1
 
(9)
αD1  βD1
2=n2 ¼ αD2  βD2
2=n1 (10)
On multiplication of Eq. (10) by 1/α, then
n1d1 þ n1
d1
2
α=β
¼ n2d2 þ n2
d2
2
α=β
(11)
Substituting n1 = 30, d1 = 2 Gy (D1 = n1d1 = 60 Gy), and n2 = 20, we obtain the
same Eq. (7) but without the dimension Gy1.5
20d 1þ
d
1:5
 
¼ 140 (12)
From the Eq. (11) one can derive the current equivalent dose in 2-Gy fractions
(EQD2) in Gy, that is, the Eq. (14), if one substitutes n1 = n2 and d2 = 2Gy transform
the Eq. (11) as
D1 þD1
2Gy
α=β
¼ D2 þD2
d
α=β
(13)
where D1 = EQD2 and D2 = D = nd, then
EQD2 ¼ D dþ α=βð Þ= 2Gyþ α=βð Þ (14)
This derivation does not need creation of the BED.
With the introduction of BED in radiotherapy, the radiation biological effects
of radiation treatments have been characterized with BED with generic values
α/β = 10 Gy for tumors and α/β = 3 Gy for normal tissues.
While the BED expression, the Eq. (3), has only one parameter, α/β, the
LQS(n,D) has two: α and β. Therefore, a tissue with α = 1 Gy1 and α/β = 10 Gy that
receives 60 Gy in 30 fractions, that is, d = 2 Gy, will have a biological radiation
effect of 9.1% of cell survival.
The cell repopulation (CR) has been introduced in Eq. (3) as
BED ¼ D 1þ
d
∝=β
 
 K T TKð Þ (15)
where T is the overall treatment duration.
Tk is the time when the cell repopulation starts.
K is the factor in Gy/day. According to [4], it is the daily BED equivalent of
repopulation.
The CR can be introduced in Eq. (2) as
LQS n,Dð Þ ¼ exp αD βD2=n
 
þ KS T TKð Þ (16)
where KS is the factor in 1/day that represents the rate of the CR per day.
The authors of [4] have highlighted that BEDs are additive. It means that if
radiotherapy is given in multiple phases, then the BED for each phase can be
summated to give the total BED.
Actually, the RBEfs are additive, that is, the biological damages increase when
number of irradiation phases increase.
4
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2.1.1 The BED in interrupted treatments
Many of the current works, such as [5–8] related with the interrupted treatment
use directly the BED expression or with some modifications that involve elements,
like the cell repopulation.
The BED is one of the most current important tools for compensating
interrupted radiation treatments, where, as described in [5] three values of BED
(original for the initial prescription, applied before the interruption and a new for
compensating the interruption) are considered.
2.2 The BED in brachytherapy (BT)
The BT may be delivered at high, medium, or low dose rates, respectively HDR,
MDR, or LDR.
The BED is also expressed as the product of the total physical dose (D) and a
dimensionless factor RE as
BED ¼ D ∗RE: (17)
Within of the BED expression, they have tried of including other factors affect-
ing the RBEfs, such as cell sublethal damage (SL), cell repair (Rt), and repopulation
(Pt). These inclusions are notary in the BT as shown in [9].
The works of [9–11] are strongly based on the BED. Here the factors affecting
RBEf are added in the BED expression or included in its dimensionless subpart, the
RE. More than 16 equations modifying Eq. (17) have been developed in this work.
The Pt effect is considered in the BED expression as:
BED ¼ D ∗RE RCF (18)
RCF ¼ K ∗ T  Tdelay
 
(19)
where T is the overall time, Tdelay is the delay time after the beginning of
treatment before the repopulation rate becomes significant, and K is a parameter of
this model.
The Rt effect for a continuous low dose rate is considered into RE as a complex
expression in [9]. In the same reference, for permanent implant, the decay of the
radioactive sources is incorporated in the factor RE of Eq. (17) as
RE ¼ 1þ
R0
μþ λð Þ α=β
  (20)
where R0 is the initial dose rate, and λ is the radionuclide decay constant.
3. The radiation biological effect (RBEf)
After the first fraction of irradiation to a living tissue region with a dose d, a
number of killed and sublethally damaged cells appear. The mean outcomes of the
radiation interactions with the cells are probabilistically related as
K þ SLþ U ¼ 1 100%ð Þ (21)
S ¼ SLþ U (22)
K þ S ¼ 1 100%ð Þ (23)
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K ¼ 1 S (24)
where K is the mean cell kill; SL is the mean cell sublethal damage; U is the mean
undamaged cell; and S is the mean cell survival. Figure 1 is a representation of
RBEfs defined by the mean values of the cell kill, sublethally damaged cell, as well
undamaged cell. These are the immediate results of first fraction of irradiation with
a dose d in a living tissue.
4. The radiobiological computational simulators (RCSs)
The computational simulations have led to the development of three
radiobiological simulators that determine TCP and mean RBEFs in normal tissue for
regular/interrupted treatments, as well as one that obtains similar probabilistic
distributions to binomial and Poisson ones. The first application is discussed in [12].
The MatLab applications of these simulators are publicly available in the repository
of [13].
The TCP has been traditionally obtained from experimental/observational data,
complex phenomenological/mechanistic models as shown in [14]. The TCP
computational-calculation methodology simulates possible situations of an irradi-
ated tumor, and is based on probabilistic analysis of three possible kinds of cells and
their final results during the interactions for a tumor homogeneously irradiated in a
fractionated regimen. The cell repair is taken into account as a temporal process
during the interfractions.
Given there will be tumor control when tumor cells are all killed by radiation, it
allows to determine TCP based on its probabilistic definition in the computational
simulations.
In the region with the minimum dose per fraction of a tumor heterogeneously
irradiated, there is the highest value of the cell survival shown by Eq. (1); that is,
there is the lowest value of probability of cell kill. For this reason, the TCP should be
calculated analyzing the results of interactions in this region, and it is not necessary
to consider other tumor regions.
For simulating a fractionated/interrupted treatment, it is considered the
following:
Figure 1.
Representation of the radiation biological effects (RBFs) defined by cell kill (K) and sublethally damaged cell
(SL), and undamaged cell. Abbreviations: dUmin and dUmax: Respectively the lower and upper limit for
stochastic region of U; dKmin and dKmax: Respectively the lower and upper limit for stochastic region of K;
dminSL and dmaxSL: Respectively the lower and upper limit for stochastic region of SL; dmlSL: Value of d with
maximum of SL; MaxproSL: Maximum value of SL.
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• The first fraction generates a mean nkc killed cells, nslc sublethally damaged
cells, and nudc undamaged cells from the total cells NTC.
• For the second and successive fractions, the three kinds of cells are analyzed in
their possible final outcomes in each fraction.
• The radiation can interact with a killed cell or a survived cell. If a random
number gnum is generated, and gnum < = nkc/NTC, then the cell is killed, but
is survived.
• For a killed cell, the simulator will analyze a new cell; but for a sublethally
damaged cell, there are two possibilities: the cell is undamaged or sublethally
damaged. This is defined with a new gnum > nslc/(nslc + nudc) for a
undamaged cell.
• For an undamaged cell, if a new gnum < probability for cell kill (K), this cell
will die, but if gnum <= (K+ probability for cell sublethal damage), this is
become in a sublethally damaged.
• For a sublethally damaged cell (SLDC) there is a range of damage degree. Two
new random numbers gnum1 and gnum2 are generated, and let us define
KSL = max(gnum1;1-gnum1). If gnum2 < =KSL, the cell will die, but is kept as
a SLDC. The previous condition is associated to a major probability of killing
the SLDC.
• While the number of fractions increases, nkc increases, and nudc decreases.
The nslc can increase or decrease after the second and successive fractions.
• The number of repaired cells is determined after each fraction or during an
interruption.
• TCP is calculated as ratio of simulations with nkc = NTC and total of them.
• The radiosensitivity for cell kill (K) is calculated from Eq. (1) as
K = 1  LQS(d)
• Eq. (22) shows that survived cells involve sublethally damaged and undamaged
cells. The current radiosensitivity studies only report mean values of
probability for S that is the sum of probabilities for SL and U, so we have
assumed the probability for SL as SL < = S in our radiobiological simulators.
Eq. (1) represents cell survival probability, that is, mean value of the ratio of the
sublethally damaged cells and total of them, when a determined living tissue char-
acterized with parameters α and α/β is homogenously irradiated with one fraction of
dose d. For this reason, this equation can be considered for whatever healthy cell of
a determined tissue as probability of becoming in survived cell after irradiation.
Given cell kill is a probabilistic complement of cell survival, then cell kill probability
is equal to
K qð Þ ¼ 1 LQ S dð Þ (25)
Our computational simulations have not been previously applied by the current
Monte Carlo methods. In the radiobiological modeling and simulation field applied
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to radiotherapy, this methodology will represent a big contribution due to one
potential innovation being that rather than evaluating TCP by analytically calculat-
ing, the TCP is calculated based on its own probabilistic definition.
Contrary to TCP, the normal tissue complication probability (NTCP) calculation
does not have easy way for being determined in the RCSs. Therefore, we have
suggested assuming similar-Poisson distributions for the NTCPs, and evaluating
safety in the radiation treatments with NTCP0 (normal tissue non-complication
probability).
4.1 The RCS in radiotherapy
In [15], authors recognize that BED formula does not take into account altered
fractionation, like twice-daily fractionation. The radiobiological simulators do not
have the quoted limitation of the BED. Using computational simulations one can
simulate any schedule of fractionation.
Example 1. A normal tissue (NT) region that is characterized with
α = 0.0683Gy1 and α/β = 1.5Gy; for d = 0.1Gy, its radiosensitivity for cell sublethal
damage is equal to 1%. As result of simulating this NT region with cell repair equal
to 40% and cell density 107cells/cm3, in 30 fractions, the mean cell kill is 30% and
mean cell sublethal damage is 0.249%.
As external beam radiotherapy, BT is an activity that involves interactions of
ionizing radiations with living tissues, which produce RBEfs into these tissues. The
specific treatment duration will depend on many different factors, including the
required rate of dose delivery and the type, size, and location of the cancer, and is
still calculated from prescribed dose.
Although the authors have not developed radiobiological simulators for BT, the
methodology of these tools can be extended to this radiation therapy.
4.1.1 The RCS in interrupted treatments
An interrupted treatment is a fractionated one, where there is a long-time period
greater than the normal interfractions. During the interruption, the sublethally
damaged cells have a major possibility of being repaired than during the
interfractions of a regular treatment.
Nowadays, the interrupted treatment is evaluated with only a radiobiological
tool, the BED. The implementation of the RCSs in the interrupted treatments will
represent an extension of the new methodology already applied for the regular
treatment.
Cell repopulation, like cell repair, is one of the temporal cellular processes, and is
related with the tumor growth, so for an interrupted treatment should be compen-
sating with an increase of the field of the radiation beam.
5. Conclusions
While the derivation of the LQ S(n,D) model for fractionated regimen considers
a 100% cell repair, that is, 0% of sublethally damaged cells (SLDCs), radiobiological
simulator methodology takes into account the presence of SLDCs, as well as a cell
repair <100% during the interfractions. This makes a better real simulation of the
process of interaction of ionizing radiation with living tissues.
The BED is a virtual and redundant radiobiological concept because of this being
just a processed subpart of the LQ S(n,D) model by means of a mathematical
derivation, and its expression does not model neither physical nor biological
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quantity, is not associated to a real quantity. When you create models for
establishing relationships among real quantities, you must not use them for creating
new metrics, which happened with the LQ S(n,D) formalism and the BED. Really
there is not BED, but RBEf defined by cell kill and sublethal damage.
BED is commonly used for isoeffective dose calculations; but one can use
Eq. (2), the LQ S(n,D) for this purposes, that is, this usefulness has been possible
without introducing the BED.
The radiobiological (RB) simulators show that radiation produces radiation bio-
logical effects (RBEfs) instead of BED, which is only a mathematical result of
processing the exponential part of the linear-quadratic cell survival model for a
fractionated treatment, the LQ S(n,D). It will be a big incoherence if we continue
using the BED that is not a real physical quantity. The killed and sublethal damaged
cells define the RBEfs. The survived cells are complementing of the former, that is,
S = 1  K, where S: cell survival and K: cell kill.
BED is an unreal quantity, whose introduction in the radiation therapies has
transformed the essential quantifications in the interactions of ionizing radiations
with living tissues, where these should be quantified with ratios of cells affected by
radiation and total of them in the irradiated tissues.
The parameters used in the RB simulators, such as killed, sublethally damaged,
and undamaged cells are strongly associated to fractionated/interrupted treatments,
but they have little familiarization compared with the widely used cell survival.
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